sintx.com (SINT) Short-Term Debt to Capital

Sintx Technologies (SINT), having reached maturity, is expanding the application of its ceramics into energy and defense systems to complement traditional implants. This chart of stock quotes on GURU.Markets reflects the asset's dynamics, where the indicator stands at 0.08. Stable B2B contracts are guaranteed by strict FDA oversight, while the unique antibacterial properties of the materials grant the company significant pricing power.

Sintx Technologies innovations in orthopedic ceramics require colossal expenditures, which is reflected in the ratio of short-term debt to equity. This coefficient compares liabilities with a maturity of up to one year against net assets, revealing the risk of cash flow gaps in the event of a working capital deficit. For an investor, an increase in this metric signals the company's critical dependence on external refinancing and equity issuances.